ALB and hepatocellular carcinoma: Patients with the following features were excluded: ALT or AST > 250 (n = 662), missing BMI, AST, ALT, platelet count, or albumin levels (n = 2,839), missing race/ethnicity (n = 122), and codes for cirrhosis or HCC at the time of study entry (n = 236) (Fig 1).